🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to evaluate the efficacy of ixekizumab do...
Status
Completed
Location
Total Skin and Beauty Dermatology Center PC
Start Date
2015-08
Trial ID
NCT02513550
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of ixekizum...
Status
Completed
Location
Total Skin and Beauty Dermatology Center PC
Start Date
2018-11-09
Trial ID
NCT03573323
Treatments Being Tested
This study will assess the safety and efficacy of LY2439821 compared to pla...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-11-16
Trial ID
NCT01474512
Treatments Being Tested
The main purpose of this study is to evaluate the safety and long-term effi...
Status
Completed
Location
Arizona Arthritis & Rheumatology Research
Start Date
2015-09-14
Trial ID
NCT02584855
Treatments Being Tested
The main purpose of this study is to evaluate how effective and safe the st...
Status
Completed
Location
Rheumatology Associates PC
Start Date
2014-12-31
Trial ID
NCT02349295
Treatments Being Tested
The main purpose of this study is to investigate the safety and tolerabilit...
Status
Completed
Location
King George Hospital
Start Date
2023-06-27
Trial ID
NCT05855967
Treatments Being Tested
The reason for this study is to see if the study drug ixekizumab is safe an...
Status
Active Not Recruiting
Location
Instituto CAICI SRL Loc. 15
Start Date
2021-04-13
Trial ID
NCT04527380
Treatments Being Tested
This study will assess the safety and efficacy of ixekizumab (LY2439821) co...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2012-12
Trial ID
NCT01695239
Treatments Being Tested
To detect onset of activity of ixekizumab in participants with moderate-to-...
Status
Completed
Location
Mount Sinai School of Medicine Dermatology Clinical Trials
Start Date
2015-04
Trial ID
NCT02387801
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy and safety of th...
Status
Completed
Location
Southern California Dermatology
Start Date
2016-04
Trial ID
NCT02718898
Treatments Being Tested